California Hepatitis C Task Force

California Hepatitis C Task Force The California Hepatitis C Task Force will develop and improve HCV prevention, education, treatment, testing and reporting practices.

We will support policy that removes barriers and improves the quality and access to care for all Californians. The California Hepatitis C Task Force will develop models and improve existing HCV prevention, education, treatment, testing and reporting practices. We will support policy that removes barriers and provides incentives to improve the quality of patient centered care, prevents new incidences of chronic hepatitis and promotes best practices for the delivery of evidence based treatments for viral hepatitis.

Pakistan received a donation of medicines from Egypt to support the elimination of hepatitis C, fighting together for th...
11/18/2025

Pakistan received a donation of medicines from Egypt to support the elimination of hepatitis C, fighting together for the future of world health.
Read more here:

Health minister describes Egypt as model for public health interventions.

’s newly signed legislation will allow Californians to buy insulin pens for $11 each beginning next year, expanding acce...
11/15/2025

’s newly signed legislation will allow Californians to buy insulin pens for $11 each beginning next year, expanding access to affordable, life-saving medication for patients living with .
Read more here:

California's first insulin pens will be for sale two years after the governor’s promised delivery date in 2024.

A study in Southwest Iran found that theory-based education can be successfully incorporated into harm reduction program...
11/12/2025

A study in Southwest Iran found that theory-based education can be successfully incorporated into harm reduction programs for people who use drugs, improving hepatitis B and C prevention among high-risk populations.
Read more here:

Background Substance abuse, particularly injection drug use, remains a significant public health challenge in Iran, where an estimated 2 million people use illicit drugs daily. Injection drug users are at high risk for bloodborne infections such as hepatitis B and C, which contribute substantially t...

China has approved the world’s first drug targeting a functional cure for hepatitis B that will be used with antiviral t...
11/11/2025

China has approved the world’s first drug targeting a functional cure for hepatitis B that will be used with antiviral therapy for clearance of the disease surface antigen.
Read more here:

China has approved the world's first domestically developed drug designed to achieve a functional cure for hepatitis B, marking a significant step in the global fight against the chronic liver infection.

A study in   examines how updated fatty liver disease terminology relates to obesity, insulin resistance, and   — offeri...
11/10/2025

A study in examines how updated fatty liver disease terminology relates to obesity, insulin resistance, and — offering insights for prevention and treatment strategies.
Read more here:

Background Definitions of nonalcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated FLD (MAFLD), and steatotic liver disease (SLD) have been proposed to better guide clinical practice and epidemiological studies. The effects of the nomenclature on the incidence of FLD and its associ...

Prague faces increased hepatitis A cases, with health officials reporting nearly 890 cases in the capital, including alm...
11/07/2025

Prague faces increased hepatitis A cases, with health officials reporting nearly 890 cases in the capital, including almost 160 cases involving children.
Read more here:

Hepatitis A is spreading fast in Prague, with over 60 new cases this week—matching the past three years—and infections reaching other regions.

11/06/2025

A UK biotech company aims to increase liver transplant accessibility by testing new technologies that repair and regenerate donated livers for the future of transplant accessibility.
Read more here: https://tinyurl.com/yzct4nk3

November is Diabetes Awareness Month! The  is celebrating by dispelling common myths and providing free A1C screenings t...
11/04/2025

November is Diabetes Awareness Month! The is celebrating by dispelling common myths and providing free A1C screenings to all blood donors who haven’t tested in the past 12 months.
Learn more here:

Diabetes affects millions across the U.S., often silently, and can lead to serious complications like kidney failure, blindness, amputations and increased risk of heart disease and stroke. This November, the American Red Cross is spotlighting diabetes prevention by offering free A1C screenings to bl...

Did you know? The Centers for Disease Control and Prevention recommends routine   screening for all patients aged 13–64 ...
10/30/2025

Did you know? The Centers for Disease Control and Prevention recommends routine screening for all patients aged 13–64 as part of routine healthcare. Early detection saves lives and understanding HIV care is crucial.
Learn more:

Published clinical guidelines for HIV.

Alcohol-related   and cancer are on the rise in the U.S., threatening the health of millions. Nearly 80% increase in alc...
10/29/2025

Alcohol-related and cancer are on the rise in the U.S., threatening the health of millions. Nearly 80% increase in alcohol-associated liver deaths over 20 years shows this is a serious American health crisis. Learn more:

Alcohol is leaving a bigger mark on Americans’ health than many realize. New research shows that drinking drives the surge in liver disease and cancer deaths across the country. 

Hepatitis B vaccination is recommended for all infants at birth, regardless of maternal HBV status. Early protection is ...
10/26/2025

Hepatitis B vaccination is recommended for all infants at birth, regardless of maternal HBV status. Early protection is crucial! Learn more about recommendations for screening, testing, and vaccination.

Learn hepatitis B vaccine recommendations, precautions, administration and more.

10/22/2025

Michigan's harm reduction programs are making a significant impact by saving lives and preventing hepatitis C cases through syringe services, naloxone distribution, and education. Learn more: https://tinyurl.com/34mxm9ka

Address

Petaluma, CA
94954

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm
Saturday 10am - 8pm
Sunday 11am - 7pm

Alerts

Be the first to know and let us send you an email when California Hepatitis C Task Force posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram